For virologically suppressed adult patients with HIV-1. See Full Indication.
JULUCA | Milestones in the Treatment of HIV-1
1987
Early Antiretroviral Therapy (ART):
Zidovudine (AZT) is the first medication approved for the treatment of HIV-11
1996
HAART:
Combinations of certain ARTs are effective regimens, but may require multiple pills taken more than once a day1
2006
Once-Daily STRs:
Single-tablet, 3-drug regimens achieve virologic suppression with 1 pill taken once per day1
2017
A Complete, Dolutegravir-Based, 2-Drug Regimen:
The first dolutegravir-based, 2-drug regimen in 1 tablet indicated for virologically suppressed adult patients with HIV-1
HAART=highly active antiretroviral therapy; STRs=single-tablet regimens.
Many Patients Could Be on ART for 40 or More Years2


How can limiting the number of medications in an HIV-1 regimen impact a patient over the length of treatment?
References:
- FDA-approved HIV medicines. https://hivinfo.nih.gov/understanding-hiv/fact-sheets/fda-approved-hiv-medicines. Accessed September 21, 2020.
- Antiretroviral Therapy Cohort Collaboration. Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies. Lancet HIV. 2017;4(8):e349-e356.
You may also be interested in

INNOVATIVE PAIRING


CLINICAL TRIALS


RISKS & SIDE EFFECTS

DGRWCNT200011